Nicole R. Hadas Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Nicole R. Hadas.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Nicole R. Hadas. Nicole R. Hadas is See Remarks in Akebia Therapeutics, Inc. ($AKBA) and SVP, Chief Legal Officer in Akebia Therapeutics, Inc. ($AKBA) and SVP, CLO & Secretary in Akebia Therapeutics, Inc. ($AKBA) and SVP, General Counsel, Sec. in Akebia Therapeutics, Inc. ($AKBA) and VP General Counsel & Secretary in Akebia Therapeutics, Inc. ($AKBA).
Latest Insider Trading Transactions of Nicole R. Hadas
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 01 2021 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, Chief Legal Of ... | Sell | S | 3.40 | 1,060 | 3,604 | 272,303 | 273.4 K to 272.3 K (-0.39 %) |
Mar 18 2021 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, Chief Legal Of ... | Grant | A | 0.00 | 10,192 | 0 | 273,363 | 263.2 K to 273.4 K (+3.87 %) |
Mar 02 2021 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, Chief Legal Of ... | Option Exercise | A | 3.46 | 110,000 | 380,600 | 110,000 | |
Mar 02 2021 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, Chief Legal Of ... | Sell | S | 3.40 | 7,976 | 27,087 | 263,171 | 271.1 K to 263.2 K (-2.94 %) |
Mar 02 2021 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, Chief Legal Of ... | Sell | S | 3.40 | 6,309 | 21,426 | 271,147 | 277.5 K to 271.1 K (-2.27 %) |
Mar 02 2021 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, Chief Legal Of ... | Grant | A | 0.00 | 62,000 | 0 | 277,456 | 215.5 K to 277.5 K (+28.78 %) |
Mar 02 2020 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, Chief Legal Of ... | Option Exercise | A | 8.87 | 105,000 | 931,350 | 105,000 | |
Mar 02 2020 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, Chief Legal Of ... | Sell | S | 8.70 | 7,050 | 61,335 | 212,756 | 219.8 K to 212.8 K (-3.21 %) |
Mar 02 2020 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, Chief Legal Of ... | Grant | A | 0.00 | 62,000 | 0 | 219,806 | 157.8 K to 219.8 K (+39.29 %) |
Apr 12 2019 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, CLO & Secretar ... | Sell | D | 7.70 | 11,929 | 91,853 | 154,806 | 166.7 K to 154.8 K (-7.15 %) |
Dec 13 2018 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, General Counse ... | Payment of Exercise | F | 8.94 | 20,175 | 180,365 | 101,284 | 121.5 K to 101.3 K (-16.61 %) |
Oct 04 2017 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, General Counse ... | Sell | S | 19.95 | 6,250 | 124,688 | 101,804 | 108.1 K to 101.8 K (-5.78 %) |
Oct 04 2017 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, General Counse ... | Sell | S | 19.64 | 1,553 | 30,501 | 108,054 | 109.6 K to 108.1 K (-1.42 %) |
Jul 06 2017 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, General Counse ... | Sell | S | 14.26 | 1,554 | 22,156 | 109,607 | 111.2 K to 109.6 K (-1.40 %) |
Feb 23 2017 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, General Counse ... | Option Exercise | A | 0.00 | 45,000 | 0 | 45,000 | |
Feb 23 2017 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, General Counse ... | Grant | A | 0.00 | 28,500 | 0 | 111,412 | 82.9 K to 111.4 K (+34.37 %) |
Jan 03 2017 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, General Counse ... | Sell | S | 10.49 | 1,810 | 18,988 | 82,912 | 84.7 K to 82.9 K (-2.14 %) |
Oct 04 2016 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, General Counse ... | Sell | S | 8.95 | 1,556 | 13,934 | 83,915 | 85.5 K to 83.9 K (-1.82 %) |
Jul 06 2016 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, General Counse ... | Sell | S | 7.47 | 1,557 | 11,625 | 85,471 | 87 K to 85.5 K (-1.79 %) |
Apr 05 2016 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, General Counse ... | Sell | S | 9.41 | 1,556 | 14,642 | 85,528 | 87.1 K to 85.5 K (-1.79 %) |
Feb 24 2016 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, General Counse ... | Option Exercise | A | 7.70 | 34,300 | 264,110 | 34,300 | |
Feb 24 2016 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, General Counse ... | Grant | A | 0.00 | 22,500 | 0 | 87,084 | 64.6 K to 87.1 K (+34.84 %) |
Jan 06 2016 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, General Counse ... | Sell | S | 12.28 | 1,811 | 22,239 | 64,584 | 66.4 K to 64.6 K (-2.73 %) |
Oct 05 2015 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, General Counse ... | Sell | S | 8.67 | 1,484 | 12,860 | 65,260 | 66.7 K to 65.3 K (-2.22 %) |
Jul 06 2015 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, General Counse ... | Sell | S | 9.54 | 1,484 | 14,160 | 66,744 | 68.2 K to 66.7 K (-2.18 %) |
Apr 06 2015 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, General Counse ... | Sell | S | 9.09 | 1,483 | 13,478 | 76,093 | 77.6 K to 76.1 K (-1.91 %) |
Apr 06 2015 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, General Counse ... | Grant | A | 9.51 | 4,539 | 43,166 | 77,576 | 73 K to 77.6 K (+6.21 %) |
Mar 10 2015 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, General Counse ... | Option Exercise | A | 11.15 | 30,000 | 334,500 | 30,000 | |
Jan 05 2015 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | VP General Counsel ... | Sell | S | 11.46 | 1,715 | 19,655 | 73,037 | 74.8 K to 73 K (-2.29 %) |
Jan 05 2015 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | VP General Counsel ... | Grant | A | 11.64 | 4,539 | 52,834 | 74,752 | 70.2 K to 74.8 K (+6.46 %) |
Dec 03 2014 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | VP General Counsel ... | Payment of Exercise | F | 11.43 | 5,910 | 67,551 | 70,213 | 76.1 K to 70.2 K (-7.76 %) |
Aug 05 2014 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | VP General Counsel ... | Option Exercise | A | 22.80 | 16,667 | 380,008 | 16,667 | |
Mar 27 2014 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | See Remarks | Buy | P | 17.00 | 3,500 | 59,500 | 76,123 | 72.6 K to 76.1 K (+4.82 %) |
Page: 1